MilliporeSigma
All Photos(1)

Documents

A9666

Sigma-Aldrich

Azaserine-Hypoxanthine 50x

Hybri-Max, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma

Sign Into View Organizational & Contract Pricing

Synonym(s):
O-Diazoacetyl-L-serine-hypoxanthine
NACRES:
NA.75

biological source

synthetic (organic)

Quality Level

grade

Hybri-Max

sterility

γ-irradiated

product line

BioXtra

form

lyophilized powder

technique(s)

cell culture | hybridoma: suitable

impurities

endotoxin, tested

shipped in

dry ice

storage temp.

−20°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
H0137O5003A5159
vibrant-m

A9666

Azaserine-Hypoxanthine 50x

vibrant-m

O5003

OPI Media Supplement

vibrant-m

A5159

Aminopterin

sterility

γ-irradiated

sterility

γ-irradiated

sterility

γ-irradiated

sterility

γ-irradiated

biological source

synthetic (organic)

biological source

-

biological source

-

biological source

synthetic

form

lyophilized powder

form

lyophilized powder

form

powder

form

lyophilized powder

impurities

endotoxin, tested

impurities

endotoxin, tested

impurities

endotoxin, tested

impurities

endotoxin, tested

grade

Hybri-Max

grade

-

grade

Hybri-Max

grade

Hybri-Max

General description

Azaserine-Hypoxanthine is used to stimulate cell proliferation in cell culture.

Application

Azaserine-Hypoxanthine 50x has been used in hybridoma cell culture.
Qualified for use in hybridoma cell culture applications as a selection agent.

Reconstitution

Reconstitute contents of vial with 10 mL sterile cell culture medium. Stock solution is sufficient to prepare 500 mL medium. Final working concentration: 5.7 μM azaserine, 100 μM hypoxanthine.

Legal Information

Hybri-Max is a trademark of Sigma-Aldrich Co. LLC

pictograms

Exclamation markHealth hazard

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

Product numbers are combined with Pack Sizes/Quantity when displayed on the website (example: T1503-25G). Please make sure you enter ONLY the product number in the Product Number field (example: T1503).

Example:

T1503
Product Number
-
25G
Pack Size/Quantity

Additional examples:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

enter as 1.000309185)

Having trouble? Feel free to contact Technical Service for assistance.

Lot and Batch Numbers can be found on a product's label following the words 'Lot' or 'Batch'.

Aldrich Products

  • For a lot number such as TO09019TO, enter it as 09019TO (without the first two letters 'TO').

  • For a lot number with a filling-code such as 05427ES-021, enter it as 05427ES (without the filling-code '-021').

  • For a lot number with a filling-code such as STBB0728K9, enter it as STBB0728 without the filling-code 'K9'.

Not Finding What You Are Looking For?

In some cases, a COA may not be available online. If your search was unable to find the COA you can request one.

Request COA

Customers Also Viewed

Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay D,et al.
The Journal of Experimental Medicine, 177(4), 999-1008 (1993)
Handbook of Mutagenicity Test Procedures, 350-350 (2012)
Handbook of Mutagenicity Test Procedures, 350-350 (2012)
Michael X Henderson et al.
Neurobiology of disease, 136, 104712-104712 (2019-12-15)
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are progressive neurodegenerative diseases for which there is no disease-modifying treatment. PD and DLB are characterized by aggregation of the synaptic protein α-synuclein, and there is compelling evidence to suggest that

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service